Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Stopping aspirin after coronary artery bypass surgery can allow platelets to clump more easily, raising the risk of graft narrowing or closure, heart attack, stroke, and death, with the greatest danger in the first weeks after the medication is discontinued. Timing matters, since aspirin is usually started within 24 hours of surgery and continued indefinitely, and abrupt discontinuation has been linked to a rebound clotting effect. There are important exceptions, including active bleeding, planned dental or surgical procedures, and cases where a doctor substitutes or adds another antiplatelet drug, so several factors must be weighed before making any change. See below to understand more about the warning signs, recovery timelines, and questions to bring to your cardiologist.
If you have missed doses, stopped aspirin, or are noticing chest discomfort, shortness of breath, unusual bruising, or bleeding, a free, instant, online symptom check can help you sort urgent red flags from routine concerns in just a few minutes. It is private, requires no appointment, and gives you clear, personalized next steps so you can decide whether to call your surgical team now or raise it at your next visit.
Last reviewed for medical accuracy: 09/26/2026
Aspirin is a cornerstone of care for patients who have undergone coronary artery bypass grafting (CABG). It helps keep new grafts open, reduces the chance of clots, and lowers the risk of heart attack or stroke. Suddenly stopping aspirin can undermine these benefits and lead to serious complications. Below, we explain what happens when you discontinue aspirin after bypass surgery, what risks you face, and what steps you can take to stay safe.
Clinical guidelines from the American Heart Association (AHA) and the American College of Cardiology (ACC) recommend lifelong aspirin therapy after CABG unless there’s a clear contraindication.
Stopping aspirin abruptly—especially within the first year after bypass—can lead to a series of serious problems:
Graft Occlusion
Increased Risk of Myocardial Infarction
Stroke
Higher Mortality
Revascularization Procedures
If you stop aspirin and begin to form clots in your grafts, you may notice:
If you experience any of these symptoms, don’t wait—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, to guide your next steps. It’s a quick way to assess urgency and learn if you should call emergency services or speak to a healthcare professional right away.
Some patients worry about bleeding (for example, gastrointestinal bleeding) and stop aspirin on their own. While bleeding is a valid concern, suddenly stopping aspirin often carries a greater risk than continuing it:
Never make changes without professional guidance—managing bleeding risk is a balance that requires personalized assessment.
Talk to Your Cardiologist or Surgeon
Review Other Medications
Consider Dose Timing
Follow Up Regularly
Even if you’re on aspirin, you still need to be alert for signs of a heart attack or stroke. If you notice:
Call emergency services (e.g., 911) right away.
If you’re unsure about your aspirin therapy or if you experience serious symptoms, speak to a doctor. Never stop or change your dosage without professional guidance.
(References)
* Deng Y, Pisklak PV, Lee VV, Tolpin DA, Collard CD, Elayda MA, Coselli J, Pan W. Association Between Preoperative Aspirin-dosing Strategy and Mortality After Coronary Artery Bypass Graft Surgery. Ann Surg. 2015 Dec;262(6):1150-6. doi: 10.1097/SLA.0000000000000951. PMID: 25361218.
* Saw J, Wong GC, Mayo J, Bernstein V, Mancini GB, Ye J, Skarsgard P, Starovoytov A, Cairns J. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery. Heart. 2016 May 15;102(10):763-9. doi: 10.1136/heartjnl-2015-308691. Epub 2016 Feb 18. PMID: 26891756.
* Lee J, Jung CW, Jeon Y, Kim TK, Cho YJ, Koo CH, Choi YH, Kim KB, Hwang HY, Kim HR, Park JY. Effects of preoperative aspirin on perioperative platelet activation and dysfunction in patients undergoing off-pump coronary artery bypass graft surgery: A prospective randomized study. PLoS One. 2017;12(7):e0180466. doi: 10.1371/journal.pone.0180466. Epub 2017 Jul 17. PMID: 28715503; PMCID: PMC5513419.
* Zhao Q, Zhu Y, Xu Z, Cheng Z, Mei J, Chen X, Wang X. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial. JAMA. 2018 Apr 24;319(16):1677-1686. doi: 10.1001/jama.2018.3197. PMID: 29710164; PMCID: PMC5933396.
* Ding Q, Liu H, Zhang Z, Goldhammer J, Yuen E, Li Z, Yao L, Young N, Boyd D, Weintraub W, Morris R, Sun J. Perioperative aspirin and long-term survival in patients undergoing coronary artery bypass graft. Sci Rep. 2018 Nov 19;8(1):17051. doi: 10.1038/s41598-018-35208-7. Epub 2018 Nov 19. PMID: 30451948; PMCID: PMC6242822.
* Aboul-Hassan SS, Marczak J, Stankowski T, Peksa M, Nawotka M, Stanislawski R, Cichon R. Association between preoperative aspirin and acute kidney injury following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2020 Sep;160(3):712-719. doi: 10.1016/j.jtcvs.2019.08.119. Epub 2019 Sep 25. PMID: 31653428.
* Wang Z, Li X, Ye Y, Xia L, Zou Y, Xu Q, Yao Y, Li X, Lv Q. Preoperative treatment with clopidogrel and ticagrelor on bleeding complications in off-pump coronary artery bypass grafting. Thromb Res. 2022 Nov;219:70-76. doi: 10.1016/j.thromres.2022.09.010. Epub 2022 Sep 15. PMID: 36126565.
* Zhu Y, Zhang W, Dimagli A, Han L, Cheng Z, Mei J, Chen X, Wang X, Zhou Y, Xue Q, Hu J, Tang M, Wang R, Song Y, Kang L, Redfors B, Gaudino M, Zhao Q. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. BMJ. 2024 Jun 11;385:e075707. doi: 10.1136/bmj-2023-075707. Epub 2024 Jun 11. PMID: 38862179; PMCID: PMC11165385.
* Sandner S, Gaudino M, Agewall S, Bonalumi G, Bonaros N, Czerny M, Jeppsson A, Milojevic M, Niessner A, Parolari A, Sulzgruber P, Tamargo J, Thielmann M, Wassmann S, Zientara A, Dobrev D. Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2026 May 21;47(20):2419-2436. doi: 10.1093/eurheartj/ehaf423. PMID: 40884067.
* Jeppsson A, James S, Moller CH, Malm CJ, Dalén M, Vanky F, Modrau IS, Andersen K, Anttila V, Atroshchenko GV, Barbu M, Dreifaldt M, El-Akkawi AI, Friberg Ö, Gudbjartsson T, Gunn J, Haaverstad R, Halonen J, Hansson EC, Holm J, Husso A, Juvonen T, Jakobsen Ø, Jideus L, Johannesson E, Jonsson Holmdahl A, Jonsson K, Kolseth SM, Krasniqi L, Mäkelä T, Mennander A, Mohagen Krogstad LE, Rafiq S, Raivio P, Riber L, Tahir A, Thorsen C, Tønnessen T, Wahba A, Zindovic I, Pivodic A, Nielsen SJ, Erlinge D, Alfredsson J, Sartipy U, TACSI Trial Group., TACSI Trial Group. Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome. N Engl J Med. 2025 Dec 11;393(23):2313-2323. doi: 10.1056/NEJMoa2508026. Epub 2025 Sep 1. PMID: 40888737.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.